Scinai Immunotherapeutics (2F50) Revenue

0 Followers

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had a revenue of 467.90K in the quarter ending Jun 30, 2026, with 73.94%. This bring the company's revenue in the last twelve months to 1.49M, Increased -1.12%. In the fiscal year ending Mar 31, 2026, Scinai Immunotherapeutics had annual revenue of 1.31M with 99.24% growth.

Revenue (ttm)

1.49M

Revenue Growth

―

P/S Ratio

0.21

Revenue/Employee

€29,133

Employees

Market Cap

€273.02K

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	1.31M	653.00K	+99.24%
Mar 31, 2025	658.00K	―	+∞%
Dec 31, 2023	―	―	―
Mar 31, 2023	―	―	―
Dec 31, 2021	―	―	―
Mar 31, 2021	―	―	―
Mar 31, 2020	―	―	―
Mar 31, 2019	―	―	―
Dec 31, 2017	―	―	―